Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass Index
Backgound
Adiposity is associated with cystatin C. Cystatin C–based glomerular filtration rate (GFR) equations may result in overestimation of chronic kidney disease (CKD) prevalence at greater body mass index (BMI) levels.
Study Design
Cross-sectional.
Setting & Participants
6,709 US adult Third National Health and Nutrition Examination Survey participants.
Factor
BMI.
Outcome
Absolute percentage of difference in prevalence of stage 3 or 4 CKD between creatinine- and cystatin C–based estimating equations by level of BMI.
Measurements
Normal weight, overweight, and obesity were defined as BMI of 18.5 to less than 25.0, 25 to less than 30.0, and 30 kg/m2 or greater, respectively. Stage 3 or 4 CKD (estimated glomerular filtration rate [eGFR], 15 to 59 mL/min/1.73 m2) was defined using the 4-variable creatinine-based Modification of Diet in Renal Disease Study equation (eGFRMDRD); cystatin C level, age, sex, and race equation (eGFRCysC,age,sex,race); cystatin C–only equation (eGFRCysC); cystatin C level of 1.12 mg/L or greater (increased cystatin C); and an equation incorporating serum creatinine level, cystatin C level, age, sex, and race (eGFRCr,CysC,age,sex,race).
Results
Differences in stage 3 or 4 CKD prevalence estimates between eGFRCysC,age,sex,race, eGFRCysC, and increased cystatin C, separately, and eGFRMDRD were greater at higher BMI levels. Specifically, compared with estimates derived using eGFRMDRD for normal-weight, overweight, and obese participants, estimated prevalences of stage 3 or 4 CKD were 2.1%, 3.0%, and 6.5% greater when estimated by using eGFRCysC,age,sex,race (P trend = 0.005); 0.1%, 0.6%, and 2.2% greater for eGFRCysC (P trend = 0.03); 2.9%, 5.2%, and 9.5% greater for increased cystatin C (P trend < 0.001); and −0.1%, −0.4%, and 0.0% greater for eGFRCr,CysC,age,sex,race, respectively (P trend = 0.7).
Limitations
No gold-standard measure of GFR was available.
Conclusions
BMI may influence the estimated prevalence of stage 3 or 4 CKD when cystatin C–based equations are used.
Index Words: Chronic kidney insufficiency, cystatin C, creatinine, glomerular filtration rate, body mass index
To access this article, please choose from the options below
Originally published online as doi:10.1053/j.ajkd.2008.12.043 on April 27, 2009.
Because the Editor-in-Chief recused himself from consideration of this manuscript, the Deputy Editor (Daniel E. Weiner, MD, MS, Tufts Medical Center) served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.
PII: S0272-6386(09)00426-0
doi:10.1053/j.ajkd.2008.12.043
© 2009 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
